ClinicalTrials.Veeva

Menu

Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

Pfizer logo

Pfizer

Status

Completed

Conditions

Arthritis, Rheumatoid

Treatments

Drug: CP-690,550

Study type

Observational

Funder types

Industry

Identifiers

NCT00414661
A3921029

Details and patient eligibility

About

The purpose of this study is to follow the health of subjects who have previously been enrolled in studies of CP-690,550 for treatment of their rheumatoid arthritis. Subjects are only eligible for this study after they have completed all participation in other studies of CP-690,550.

Full description

At their last visit of a qualifying study, eligible subjects will be given the opportunity to participate in this study.

Enrollment

162 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects who have completed all participation in any other Phase 2B or Phase 3 studies of CP-690,550 for rheumatoid arthritis.

Exclusion criteria

  • Any subject who refuses consent.

Trial design

162 participants in 1 patient group

Study group
Description:
All enrolled subjects
Treatment:
Drug: CP-690,550

Trial contacts and locations

72

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems